SARS-CoV-2	B-Reagent
Enrichment	B-Action
Sequencing	I-Action
by	O
Spiked	B-Method
Primer	I-Method
MSSPE	I-Method
method	I-Method

Nasopharyngeal	B-Reagent
and	O
oropharyngeal	B-Reagent
swabs	I-Reagent
(	O
combined	B-Action
into	O
one	B-Numerical
tube	B-Location
)	O
were	O
collected	B-Action
from	O
a	O
symptomatic	B-Reagent
patient	I-Reagent
meeting	O
case	O
definition	O
for	O
possible	O
infection	O
with	O
SARS-CoV-2	B-Reagent
.	O

Extraction	B-Method
of	O
viral	B-Reagent
nucleic	I-Reagent
acids	I-Reagent
from	O
clinical	B-Reagent
sample	I-Reagent
was	O
performed	B-Action
with	O
a	O
QIAamp	B-Device
Viral	I-Device
RNA	I-Device
Mini	I-Device
Kit	I-Device
(	O
Qiagen	O
#	O
52906	O
)	O
as	O
described	O
by	O
manufacturer	O
Extracted	B-Modifier
RNA	B-Reagent
samples	I-Reagent
were	O
DNAse-treated	B-Action
using	O
the	O
Zymo	B-Device
DNAse	I-Device
I	I-Device
kit	I-Device
.	O

The	O
nucleic	B-Reagent
acid	I-Reagent
was	O
tested	B-Action
via	O
real-time	B-Method
polymerase	I-Method
chain	I-Method
reaction	I-Method
for	O
COVID-19	B-Reagent
using	O
both	O
the	O
Drosden	B-Method
and	O
HKU	B-Method
protocols	O
published	O
by	O
the	O
World	O
Health	O
Organization	O
and	O
confirmed	B-Action
positive	B-Modifier
for	O
COVID-19	B-Reagent
on	O
January	O
27th	O
,	O
2020	O
.	O

Ct	B-Measure-Type
values	O
for	O
PUI	B-Generic-Measure
=	I-Generic-Measure
24	I-Generic-Measure
.	O

RNA	B-Reagent
was	O
quantified	B-Action
using	O
the	O
Qubit	B-Device
High	I-Device
Sensitivity	I-Device
RNA	I-Device
kit	I-Device
as	O
described	O
by	O
the	O
manufacturer	O
.	O

Qubit	B-Device
input	O
RNA	B-Reagent
concentration	B-Measure-Type
for	O
PUI	B-Concentration
=	I-Concentration
6.9	I-Concentration
ng/uL	I-Concentration

Library	B-Reagent
Preparation	B-Method
was	O
performed	B-Action
with	O
the	O
NEBNext	B-Device
Ultra	I-Device
II	I-Device
non-directional	I-Device
RNA	I-Device
kit	I-Device
.	O

Fragmentation	B-Method
&	O
SARS-CoV-2	B-Reagent
primer	I-Reagent
spike	I-Reagent
in	O
Random	B-Reagent
primers	I-Reagent
at	O
1	B-Concentration
M	I-Concentration
are	O
mixed	B-Action
with	O
a	O
10	B-Concentration
M	I-Concentration
of	O
SARS-CoV-2	B-Reagent
primers	I-Reagent
(	O
see	O
below	O
)	O
at	O
a	O
1:1	B-Concentration
volume	B-Measure-Type
ratio	O
.	O

*	O
(	O
optional	O
)	O
ERCCs	B-Reagent
are	O
internal	B-Modifier
synthetic	I-Modifier
RNA	B-Reagent
controls	I-Reagent
comprised	O
of	O
92	B-Numerical
synthetic	B-Modifier
RNAs	B-Reagent
that	O
do	O
not	O
match	O
to	O
any	O
known	O
microbe	B-Reagent
in	O
the	O
NCBI	B-Device
NR/NT	I-Device
databases	I-Device
.	O

**	O
(	O
optional	O
)	O
FastSelect	B-Reagent
is	O
designed	O
for	O
removing	B-Action
human	B-Reagent
rRNA	I-Reagent
,	O
omit	B-Action
this	O
reagent	B-Mention
if	O
not	O
using	O
human	B-Modifier
derived	I-Modifier
samples	B-Reagent
and	O
only	O
incubate	B-Action
at	O
94	B-Temperature
C	I-Temperature
and	O
then	O
directly	B-Modifier
to	O
4	B-Temperature
C	I-Temperature
(	O
omit	B-Action
ramping	I-Action
down	I-Action
steps	O
)	O
.	O

Thermocycler	B-Device
(	O
heated	B-Modifier
lid	B-Seal
set	B-Action
to	O
105	B-Temperature
C	I-Temperature
)	O
:	O

8	B-Time
min	I-Time
at	O
94	B-Temperature
C	I-Temperature
(	O
Adjust	B-Action
this	O
fragmentation	B-Measure-Type
time	I-Measure-Type
depending	O
on	O
the	O
quality	B-Measure-Type
of	O
extracted	B-Modifier
RNA	B-Reagent
)	O

2	B-Time
min	I-Time
75	B-Temperature
C2	I-Temperature
min	B-Time
70	B-Temperature
C	I-Temperature

2	B-Time
min	I-Time
65	B-Temperature
C2	I-Temperature
min	B-Time
60	B-Temperature
C	I-Temperature

2	B-Time
min	I-Time
55	B-Temperature
C5	I-Temperature
min	B-Time
37	B-Temperature
C	I-Temperature

5	B-Time
min	I-Time
25	B-Temperature
C	I-Temperature
8	B-Time
min	I-Time
at	O
94	B-Temperature
C	I-Temperature
(	O
Adjust	B-Action
this	O
fragmentation	B-Measure-Type
time	I-Measure-Type
depending	O
on	O
the	O
quality	B-Measure-Type
of	O
extracted	B-Modifier
RNA	B-Reagent
)	O

5	B-Time
min	I-Time
25	B-Temperature
C	I-Temperature

The	O
73	B-Numerical
primers	B-Reagent
tile	B-Action
across	O
the	O
entire	O
SARS-CoV2	B-Reagent
genome	I-Reagent
at	O
a	O
spacing	B-Measure-Type
of	O
~400bp	B-Modifier
.	O

The	O
PDF	O
below	O
shows	O
the	O
approximate	B-Modifier
location	B-Measure-Type
of	O
the	O
primer	B-Location
binding	I-Location
sites	I-Location
.	O

First	B-Method
Strand	I-Method
Synthesis	I-Method
Mix	B-Action
the	O
following	O
by	O
pipetting	B-Action
up	B-Method
and	I-Method
down	I-Method
.	O

10	B-Time
mins	I-Time
at	O
25	B-Temperature
C	I-Temperature

15	B-Time
mins	I-Time
at	O
42	B-Temperature
C	I-Temperature

15	B-Time
mins	I-Time
at	O
70	B-Temperature
C	I-Temperature

Hold	B-Action
at	O
4	B-Temperature
C	I-Temperature
10	B-Time
mins	I-Time
at	O
25	B-Temperature
C	I-Temperature

Hold	B-Action
at	O
4	B-Temperature
C	I-Temperature

Second	B-Method
Strand	I-Method
Synthesis	I-Method
Thermocycler	B-Device
(	O
heated	B-Modifier
lid	B-Seal
off	B-Modifier
)	O
:	O

1	B-Time
hour	I-Time
at	O
16	B-Temperature
C	I-Temperature

Hold	B-Action
at	O
4	B-Temperature
C	I-Temperature

SPRI	B-Action
cleanup	I-Action

*allow	B-Action
beads	B-Reagent
to	O
sit	B-Action
in	O
RT	B-Temperature
for	O
30	B-Time
mins	I-Time
prior	O

Use	B-Action
SPRI	B-Reagent
Beads1.8x	I-Reagent
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

Prep	B-Action
80	B-Concentration
%	I-Concentration
EtOH	B-Reagent
.	O

Add	B-Action
144uL	B-Amount
of	O
room	B-Temperature
temperature	I-Temperature
beads	B-Reagent
to	O
2nd	B-Reagent
Strand	I-Reagent
Synthesis	I-Reagent
Rxn	I-Reagent
.	O

Mix	B-Action
well	B-Modifier
by	O
pipetting	B-Action
gently	B-Modifier
.	O

Pulse	B-Action
spin	I-Action
the	O
tubes	B-Location
,	O
but	O
be	O
sure	O
not	O
to	O
spin	B-Action
down	I-Action
beads	B-Reagent
.	O

Incubate	B-Action
for	O
5	B-Time
mins	I-Time
at	O
room	B-Temperature
temperature	I-Temperature
.	O

Place	B-Action
samples	B-Reagent
on	O
magnetic	B-Location
rack	I-Location
,	O
and	O
incubate	B-Action
for	O
5	B-Time
mins	I-Time
on	O
the	O
rack	B-Location
.	O

Remove	B-Action
supernatant	B-Reagent
.	O

Add	B-Action
200uL	B-Amount
of	O
80	B-Concentration
%	I-Concentration
EtOH	B-Reagent
to	O
samples	B-Reagent
while	O
on	O
the	O
magnetic	B-Location
rack	I-Location
.	O

Incubate	B-Action
at	O
room	B-Temperature
temperature	I-Temperature
for	O
30s	B-Time
then	O
remove	B-Action
the	O
supernatant	B-Reagent
.	O

Repeat	B-Action
EtOH	B-Reagent
wash	B-Action
step	O
for	O
a	O
total	O
of	O
2	B-Numerical
times	I-Numerical

Air	B-Action
dry	I-Action
the	O
beads	B-Reagent
for	O
5	B-Time
mins	I-Time
while	O
on	O
the	O
magnetic	B-Location
rack	I-Location
.	O

Remove	B-Action
tube	B-Location
from	O
magnetic	B-Location
rack	I-Location
.	O

Elute	B-Action
DNA	B-Reagent
from	O
beads	B-Reagent
into	O
53uL	B-Amount
of	O
0.1x	B-Concentration
TE	B-Reagent
Buffer	I-Reagent
,	O
10mM	B-Concentration
Tris-HCl	B-Reagent
,	O
or	O
Nuclease	B-Modifier
free	I-Modifier
water	B-Reagent
.	O

Vortex	B-Action
to	O
mix	B-Action
.	O

Spin	B-Action
tubes	B-Location
and	O
incubate	B-Action
for	O
2	B-Time
mins	I-Time
at	O
room	B-Temperature
temperature	I-Temperature
off	O
the	O
magnetic	B-Location
rack	I-Location
.	O

Place	B-Action
on	O
magnetic	B-Location
rack	I-Location
until	O
solution	B-Reagent
is	O
clear	B-Modifier
~	I-Modifier
5	B-Time
mins	I-Time
.	O

Remove	B-Action
50uL	B-Amount
of	O
the	O
supernatant	B-Reagent
and	O
transfer	B-Action
to	O
a	O
clean	B-Modifier
nuclease	I-Modifier
free	I-Modifier
PCR	B-Location
tube	I-Location
.	O

Use	B-Action
SPRI	B-Reagent
Beads	I-Reagent

1.8x	B-Concentration
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

**Checkpoint	O
:	O
Samples	B-Reagent
can	O
be	O
stored	B-Action
frozen	B-Modifier
at	O
-20	B-Temperature
C	I-Temperature
and	O
library	B-Reagent
prep	B-Action
resumed	O
the	O
next	B-Time
day	I-Time
.	O

End	B-Action
Repair	I-Action

Mix	B-Action
all	O
the	O
following	B-Mention
by	O
pipetting	B-Action
up	B-Method
and	I-Method
down	I-Method

30	B-Time
mins	I-Time
at	O
20	B-Temperature
C	I-Temperature

30	B-Time
mins	I-Time
at	O
65	B-Temperature
C	I-Temperature

Adapter	B-Method
Ligation	I-Method

dilute	B-Action
adaptor	B-Reagent
to	O
dilution	B-Reagent
prior	O
to	O
making	B-Action
master	B-Reagent
mix	I-Reagent
.	O

Adaptor	B-Reagent
concentration	B-Measure-Type
depends	O
on	O
the	O
amount	B-Measure-Type
of	O
input	B-Reagent
;	O
1:100	B-Concentration
dilution	B-Reagent
for	O
samples	B-Reagent
<	B-Modifier
5ng	B-Amount
,	O
1:25	B-Concentration
for	O
input	B-Reagent
of	O
>	B-Modifier
5ng	B-Amount

Add	B-Action
adaptor	B-Reagent
separately	B-Modifier
after	O
ligation	B-Reagent
master	I-Reagent
mix	I-Reagent
and	O
ligation	B-Reagent
enhancer	I-Reagent
to	O
avoid	B-Action
adaptor	B-Reagent
dimers	I-Reagent
.	O

Thermocycler	B-Device
(	O
heated	B-Modifier
lid	B-Seal
off	B-Modifier
)	O
:	O

15	B-Time
mins	I-Time
at	O
20	B-Temperature
C	I-Temperature
with	O
heated	B-Modifier
lid	B-Seal
off	B-Modifier

Proceed	B-Action
immediately	B-Modifier
to	O
Bead	B-Reagent
Purification	B-Method
.	O

15	B-Time
mins	I-Time
at	O
20	B-Temperature
C	I-Temperature
with	O
heated	B-Modifier
lid	B-Seal
off	B-Modifier

Proceed	B-Action
immediately	B-Modifier
to	O
Bead	B-Reagent
Purification	B-Method

Thermocycler	B-Device
(	O
heated	B-Modifier
lid	B-Seal
off	B-Modifier
)	O
:	O

SPRI	B-Action
Cleanup	I-Action

*allow	B-Action
beads	B-Reagent
to	O
sit	B-Action
in	O
RT	B-Temperature
for	O
30	B-Time
mins	I-Time
prior	O

Use	B-Action
SPRI	B-Reagent
bead	I-Reagent
0.9x	B-Concentration
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

Add	B-Action
87uL	B-Amount
of	O
room	B-Temperature
temperature	I-Temperature
beads	B-Reagent
(	O
0.9x	B-Concentration
)	O
to	O
Adaptor	B-Reagent
Ligation	I-Reagent
reaction	I-Reagent
.	O

Mix	B-Action
well	B-Modifier
.	O

Repeat	B-Action
EtOH	B-Reagent
wash	B-Action
step	O
for	O
a	O
total	O
of	O
2	B-Numerical
times	I-Numerical
.	O

Air	B-Action
dry	I-Action
the	O
beads	B-Reagent
for	O
5	B-Time
mins	I-Time
while	O
on	O
the	O
magnetic	B-Location
rack	I-Location
.	O

Elute	B-Action
DNA	B-Reagent
from	O
beads	B-Reagent
into	O
17uL	B-Amount
of	O
0.1x	B-Concentration
TE	B-Reagent
Buffer	I-Reagent
,	O
10mM	B-Concentration
Tris-HCl	B-Reagent
,	O
or	O
Nuclease	B-Modifier
free	I-Modifier
water	B-Reagent
.	O

Remove	B-Action
15uL	B-Amount
of	O
the	O
supernatant	B-Reagent
and	O
transfer	B-Action
to	O
a	O
clean	B-Modifier
nuclease	I-Modifier
free	I-Modifier
PCR	B-Location
tube	I-Location
.	O

Use	B-Action
SPRI	B-Reagent
bead	I-Reagent
0.9x	B-Concentration
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

Place	B-Action
samples	B-Reagent
on	O
magnetic	B-Location
rack	I-Location
,	O
and	O
incubate	B-Action
for	O
5	B-Time
mins	I-Time
on	O
the	O
rack	B-Location

Remove	B-Action
supernatant	B-Reagent
.	O

USER/Q5	B-Method
Indexing	I-Method
PCR	I-Method
Mix	B-Action
the	O
following	O
components	B-Reagent
by	O
pipetting	B-Action
up	B-Method
and	I-Method
down	I-Method
.	O

Cycling	B-Action
conditions	O
:	O
**	O
PCR	B-Action
cycles	I-Action
are	O
dependent	O
on	O
the	O
input	B-Reagent
RNA	I-Reagent
.	O

For	O
libraries	B-Reagent
with	O
<	B-Modifier
5ng	B-Amount
input	B-Reagent
,	O
perform	B-Action
15-19	B-Generic-Measure
cycles	I-Generic-Measure
of	O
PCR	B-Method
.	O

For	O
5-20ng	B-Amount
input	B-Reagent
,	O
perform	B-Action
10-14	B-Generic-Measure
cycles	I-Generic-Measure
of	O
PCR	B-Method
.	O

For	O
>	B-Modifier
20ng	B-Amount
input	B-Reagent
,	O
perform	B-Action
6-8	B-Generic-Measure
cycles	I-Generic-Measure
of	O
PCR	B-Method
.	O

*allow	B-Action
beads	B-Reagent
to	O
sit	B-Action
in	O
RT	B-Temperature
for	O
30	B-Time
mins	I-Time
prior	O

Use	B-Action
SPRI	B-Reagent
Beads	I-Reagent
at	O
0.8x	B-Concentration
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

Add	B-Action
43uL	B-Amount
of	O
room	B-Temperature
temperature	I-Temperature
Ampure	B-Reagent
Beads	I-Reagent
(	O
0.8x	B-Concentration
)	O
to	O
barcoded	B-Modifier
DNA	B-Reagent
.	O

Elute	B-Action
DNA	B-Reagent
from	O
beads	B-Reagent
into	O
23uLof	B-Amount
0.1x	B-Concentration
TE	B-Reagent
Buffer	I-Reagent
,	O
10mMTris-HCL	B-Concentration
,	O
or	O
Nuclease	B-Modifier
free	I-Modifier
water	B-Reagent
.	O

Remove	B-Action
20uL	B-Amount
of	O
the	O
supernatant	B-Reagent
and	O
transfer	B-Action
to	O
a	O
clean	B-Modifier
nuclease	I-Modifier
free	I-Modifier
PCR	B-Location
tube	I-Location
.	O

Use	B-Action
SPRI	B-Reagent
Beads	I-Reagent
at	O
0.8x	B-Concentration
ratio	O
of	O
beads-to-total	B-Measure-Type
volume	I-Measure-Type
of	O
sample	B-Reagent
.	O

**	O
Checkpoint	O
:	O
Libraries	B-Reagent
are	O
complete	B-Modifier
,	O
samples	B-Reagent
can	O
be	O
stored	B-Action
frozen	B-Modifier
at	O
-20	B-Temperature
C	I-Temperature
until	O
ready	O
for	O
quantification	B-Method
and	O
pooling	B-Method
.	O

Libraries	B-Reagent
were	O
quantified	B-Action
by	O
the	O
Qubit	B-Device
High	I-Device
Sensitivity	I-Device
DNA	I-Device
kit	I-Device
and	O
the	O
Agilent	B-Device
High	I-Device
Sensitivity	I-Device
D500	I-Device
DNA	I-Device
Tapestation	I-Device
assay	B-Action
.	O

If	O
adapter	B-Reagent
dimers	I-Reagent
are	O
found	B-Action
,	O
library	B-Reagent
should	O
be	O
size	B-Action
selected	I-Action
using	O
a	O
SPRI	B-Measure-Type
ratio	I-Measure-Type
of	O
0.8x	B-Concentration
.	O

Quantified	B-Modifier
library	B-Reagent
is	O
then	O
diluted	B-Action
down	I-Action
to	O
the	O
loading	B-Measure-Type
concentration	I-Measure-Type
for	O
the	O
iSeq	B-Device
,	O
100pM	B-Concentration
.	O

This	O
value	O
will	O
vary	O
depending	O
on	O
the	O
type	O
of	O
sequencer	B-Device
.	O

The	O
Illumina	B-Device
iSeq	I-Device
was	O
loaded	B-Action
with	O
20uL	B-Amount
of	O
a	O
100pM	B-Concentration
library	B-Reagent
with	O
a	O
5	B-Concentration
%	I-Concentration
PhiX	B-Reagent
spike	I-Reagent
in	I-Reagent
.	O

Metagenomic	B-Action
sequencing	I-Action
results	O
were	O
uploaded	B-Action
onto	O
IDseq.net	B-Device
directly	B-Modifier
from	O
the	O
Illumina	B-Device
Basespace	I-Device
Sequence	I-Device
Hub	I-Device
.	O

The	O
open-source	B-Modifier
cloud-based	I-Modifier
pipeline	B-Device
analyzed	B-Action
1.8	B-Numerical
million	I-Numerical
reads	B-Reagent
.	O

The	O
majority	O
of	O
reads	B-Reagent
mapped	B-Action
to	O
the	O
nasal	B-Reagent
and	O
oral	B-Reagent
microbiome	I-Reagent
.	O

Analyses	B-Method
of	O
the	O
viral	B-Reagent
components	I-Reagent
resulted	O
in	O
3,077	B-Numerical
single	B-Reagent
end	I-Reagent
reads	I-Reagent
aligning	B-Action
to	O
the	O
SARS-CoV2	B-Reagent
taxon	I-Reagent
.	O

Resulting	B-Action
reads	B-Reagent
from	O
the	O
Betacoronovirus	B-Reagent
genus	I-Reagent
were	O
downloaded	B-Action
from	O
IDseq	B-Device
and	O
mapped	B-Action
to	O
the	O
NCBI	B-Measure-Type
genome	I-Measure-Type
accession	I-Measure-Type
number	I-Measure-Type
:	O
MN908947.1	B-Generic-Measure
.	O

The	O
geneious	B-Measure-Type
alignment	I-Measure-Type
displayed	B-Action
even	O
coverage	B-Measure-Type
across	O
the	O
genome	B-Reagent
with	O
an	O
average	O
coverage	B-Measure-Type
of	O
14.9x	B-Generic-Measure
.	O

One	B-Numerical
SNP	B-Reagent
was	O
noted	B-Action
at	O
position	B-Measure-Type
25,654	B-Generic-Measure
in	O
ORF3a	B-Reagent
resulting	O
in	O
a	O
valine	B-Reagent
to	O
leucine	B-Reagent
substitution	B-Method
when	O
compared	B-Action
to	O
NCBI	B-Measure-Type
accession	I-Measure-Type
MN908947.1	B-Generic-Measure
.	O



